These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18665662)

  • 21. SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study.
    Maher-Edwards G; Dixon R; Hunter J; Gold M; Hopton G; Jacobs G; Hunter J; Williams P
    Int J Geriatr Psychiatry; 2011 May; 26(5):536-44. PubMed ID: 20872778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial.
    Rockwood K; Fay S; Gorman M; Carver D; Graham JE
    BMC Neurol; 2007 Aug; 7():26. PubMed ID: 17760991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study.
    Frölich L; Ashwood T; Nilsson J; Eckerwall G;
    J Alzheimers Dis; 2011; 24(2):363-74. PubMed ID: 21258153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis.
    Kobayashi H; Ohnishi T; Nakagawa R; Yoshizawa K
    Int J Geriatr Psychiatry; 2016 Aug; 31(8):892-904. PubMed ID: 26680338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.
    Whitehead A; Perdomo C; Pratt RD; Birks J; Wilcock GK; Evans JG
    Int J Geriatr Psychiatry; 2004 Jul; 19(7):624-33. PubMed ID: 15254918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study.
    Rogers SL; Friedhoff LT
    Eur Neuropsychopharmacol; 1998 Feb; 8(1):67-75. PubMed ID: 9452942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P; Salmon E; Hampel H; Xu Y; Richardson S; Qvitzau S; Schindler R;
    CNS Drugs; 2006; 20(4):311-25. PubMed ID: 16599649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.
    Rogers SL; Farlow MR; Doody RS; Mohs R; Friedhoff LT
    Neurology; 1998 Jan; 50(1):136-45. PubMed ID: 9443470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
    Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N
    Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
    Wilcock G; Howe I; Coles H; Lilienfeld S; Truyen L; Zhu Y; Bullock R; Kershaw P;
    Drugs Aging; 2003; 20(10):777-89. PubMed ID: 12875613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.
    Krishnan KR; Charles HC; Doraiswamy PM; Mintzer J; Weisler R; Yu X; Perdomo C; Ieni JR; Rogers S
    Am J Psychiatry; 2003 Nov; 160(11):2003-11. PubMed ID: 14594748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease.
    Wilkinson D; Schindler R; Schwam E; Waldemar G; Jones RW; Gauthier S; Lopez OL; Cummings J; Xu Y; Feldman HH
    Dement Geriatr Cogn Disord; 2009; 28(3):244-51. PubMed ID: 19786776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials.
    Román GC; Wilkinson DG; Doody RS; Black SE; Salloway SP; Schindler RJ
    Dement Geriatr Cogn Disord; 2005; 20(6):338-44. PubMed ID: 16192723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.
    Rockwood K; Howlett SE; Hoffman D; Schindler R; Mitnitski A
    Alzheimers Dement; 2017 Oct; 13(10):1098-1106. PubMed ID: 28341540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2002; (3):CD001747. PubMed ID: 12137632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial.
    Aronson S; Van Baelen B; Kavanagh S; Schwalen S
    Drugs Aging; 2009; 26(3):231-9. PubMed ID: 19358618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons between traditional medicines and pharmacotherapies for Alzheimer disease: A systematic review and meta-analysis of cognitive outcomes.
    May BH; Feng M; Hyde AJ; Hügel H; Chang SY; Dong L; Guo X; Zhang AL; Lu C; Xue CC
    Int J Geriatr Psychiatry; 2018 Mar; 33(3):449-458. PubMed ID: 29239495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
    Matthews HP; Korbey J; Wilkinson DG; Rowden J
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):713-20. PubMed ID: 10960883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design.
    Pelton GH; Andrews H; Roose SP; Marcus SM; D'Antonio K; Husn H; Petrella JR; Zannas AS; Doraiswamy PM; Devanand DP
    Contemp Clin Trials; 2014 Mar; 37(2):200-8. PubMed ID: 24315979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.